BK Polyomavirus: Immunopathology and Therapeutic Approaches
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Immunology and Immunotherapy".
Deadline for manuscript submissions: 31 July 2026 | Viewed by 15
Special Issue Editors
Interests: regulation of BK polyomavirus persistence by micro-RNAs; viral monitoring in kidney transplantation; identification of biomarkers and risk factors of BK polyomavirus-associated pathologies
Special Issue Information
Dear Colleagues,
This Special Issue, “BK Polyomavirus: Immunopathology and Therapeutic Approaches”, will mainly focus on the understanding of immune and viral balance in life-long infection with BK polyomavirus. It will also aim to bring new approaches to prevent, diagnose, or cure BK polyomavirus-associated diseases.
Most individuals are persistently infected with BK polyomavirus. The factors that maintain this persistence, or break it down to lead to pathologies such as nephropathy and hemorrhagic cystitis, are unknown. Immune system impairment, particularly due to medication during solid organ or hematopoietic stem cell transplants, is the main risk factor for the development of diseases associated with BK polyomavirus. Understanding the immunopathology of this infection is necessary for the development of preventive and curative therapies, which remain ineffective today.
We invite authors in the field to submit original research or review articles pertaining to this important and fast-progressing field of biomedicine.
Dr. Baptiste Demey
Prof. Dr. Sandrine Castelain
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- virus–host interactions
- antiviral agents
- host-directed antivirals
- BK polyomavirus
- viral immune evasion
- neutralizing antibodies
- transplantation
- biomarkers
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
